Fulgent Genetics (FLGT) Short Interest Ratio & Short Volume → My #1 investment for 2024 (From True Market Insiders) (Ad) Free FLGT Stock Alerts $22.11 -0.39 (-1.73%) (As of 05/17/2024 ET) Add Compare Share Share Short InterestStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial MediaSustainabilityStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial MediaSustainability Fulgent Genetics Short Interest DataCurrent Short Volume682,400 sharesPrevious Short Volume625,400 sharesChange Vs. Previous Month+9.11%Dollar Volume Sold Short$13.89 millionShort Interest Ratio / Days to Cover3.1Last Record DateApril 30, 2024Outstanding Shares29,920,000 sharesFloat Size19,590,000 sharesShort Percent of Float3.48%Today's Trading Volume93,350 sharesAverage Trading Volume174,479 sharesToday's Volume Vs. Average54% Short Selling Fulgent Genetics ? Sign up to receive the latest short interest report for Fulgent Genetics and its competitors with MarketBeat's FREE newsletter. Email Address Skip Charts & View Short Interest HistoryShort InterestDays to CoverShort Percent of FloatFLGT Short Interest Over TimeFLGT Days to Cover Over TimeFLGT Percentage of Float Shorted Over Time Ad True Market InsidersMy #1 investment for 2024It’s something you use every single day and don’t even know it.Click here to see my #1 investment for 2024. Fulgent Genetics Short Interest History Export to ExcelReport DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date 4/30/2024682,400 shares $13.89 million +9.1%3.5%3.1 $20.35 4/15/2024625,400 shares $12.98 million +3.5%3.1%2.9 $20.75 3/31/2024604,000 shares $13.11 million -1.2%3.0%2.9 $21.70 3/15/2024611,200 shares $13.50 million +22.6%3.2%2.9 $22.09 2/29/2024498,400 shares $11.24 million -3.6%2.6%2.2 $22.56 2/15/2024517,200 shares $13.28 million +10.1%2.7%2.7 $25.68 Get the Latest News and Ratings for FLGT and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Fulgent Genetics and its competitors with MarketBeat's FREE daily newsletter. 1/31/2024469,900 shares $11.55 million -7.5%2.5%2.5 $24.59 1/15/2024508,200 shares $14.21 million -7.9%2.7%2.4 $27.97 12/31/2023551,900 shares $15.96 million -15.0%2.9%2.5 $28.91 12/15/2023649,400 shares $18.30 million +4.7%3.4%2.8 $28.18 11/30/2023620,400 shares $17.11 million -33.4%3.2%2.8 $27.58 11/15/2023931,700 shares $25.68 million +3.1%4.9%4 $27.56 10/31/2023903,600 shares $21.63 million +5.6%4.7%3.7 $23.94 10/15/2023855,900 shares $21.31 million +4.1%4.5%3.6 $24.90 9/30/2023821,900 shares $21.98 million +49.5%4.3%3.7 $26.74 9/15/2023549,800 shares $16.31 million -8.0%2.9%2.6 $29.67 8/31/2023597,900 shares $19.59 million +9.2%3.2%2.8 $32.76 8/15/2023547,400 shares $18.65 million -10.7%2.9%2.6 $34.07 7/31/2023613,100 shares $23.81 million -8.7%3.2%2.9 $38.83 7/15/2023671,800 shares $26.04 million +6.8%3.5%3.3 $38.76 6/30/2023629,100 shares $23.30 million -5.8%3.3%3.1 $37.03 6/15/2023667,600 shares $25.51 million -10.8%3.5%3.2 $38.21 5/31/2023748,700 shares $29.78 million -7.5%3.9%3.2 $39.77 5/15/2023809,500 shares $29.51 million +7.3%4.1%3.5 $36.46 4/30/2023754,300 shares $22.30 million +1.1%3.8%3.4 $29.57 4/15/2023745,800 shares $22.99 million -12.3%3.8%3.5 $30.83 3/31/2023850,000 shares $26.54 million -26.1%4.6%3.7 $31.22 3/15/20231,150,000 shares $36.78 million +26.6%6.2%4.8 $31.98 2/28/2023908,500 shares $29.79 million +5.9%4.9%3.8 $32.79 2/15/2023857,800 shares $29.16 million -4.4%4.6%3.7 $33.99 1/31/2023896,900 shares $30.30 million -23.3%4.8%3.3 $33.78 1/15/20231,170,000 shares $38.18 million +14.7%6.3%4.3 $32.63 12/30/20221,020,000 shares $30.38 million -14.3%5.5%3.7 $29.78 12/15/20221,190,000 shares $38.60 million +4.4%6.4%4.3 $32.44 11/30/20221,140,000 shares $41.35 million -1.7%6.0%4.1 $36.27 11/15/20221,160,000 shares $42.94 million -4.9%6.1%4 $37.02 10/31/20221,220,000 shares $48.35 million -4.7%5.9%4 $39.63 10/15/20221,280,000 shares $46.58 million -2.3%6.2%4.2 $36.39 9/30/20221,310,000 shares $49.94 million -3.0%6.3%4.2 $38.12 9/15/20221,350,000 shares $55.61 million -2.9%6.5%4.3 $41.19get a piece of the profit from this land (Ad)This isn’t the prettiest land on earth. But it might be the most valuable. And you don’t have to own, lease, or rent any land.Click here to see my #1 investment for 2024. FLGT Short Interest - Frequently Asked Questions What is Fulgent Genetics' current short interest? Short interest is the volume of Fulgent Genetics shares that have been sold short but have not yet been covered or closed out. As of April 30th, traders have sold 682,400 shares of FLGT short. 3.48% of Fulgent Genetics' shares are currently sold short. Learn More on Fulgent Genetics' current short interest. What is a good short interest ratio for Fulgent Genetics? The short interest ratio, also known as the "days to cover ratio", is calculated by dividing the number of shares of a stock sold short divided by its average trading volume. A short interest ratio ranging between 1 and 4 generally indicates strong positive sentiment about a stock and a lack of short sellers. A short interest ratio of 10 or greater indicates strong pessimism about a stock. FLGT shares currently have a short interest ratio of 3.0. Learn More on Fulgent Genetics's short interest ratio. Which institutional investors are shorting Fulgent Genetics? As of the most recent reporting period, the following institutional investors, funds, and major shareholders have reported short positions of Fulgent Genetics: Walleye Trading LLC. These positions are disclosed in Form 13F filings with the Securities and Exchange Commission. What is a good short interest percentage for Fulgent Genetics? Companies that have a short interest as a percentage of float below 10% indicates positive investor sentiment and few short sellers. Stocks with a short interest percentage above 10% is considered high, suggesting some investors are pessimistic about the stock. Companies with a short interest percentage of 20% or more indicates widespread negative sentiment. 3.48% of Fulgent Genetics' floating shares are currently sold short. Is Fulgent Genetics' short interest increasing or decreasing? Fulgent Genetics saw a increase in short interest during the month of April. As of April 30th, there was short interest totaling 682,400 shares, an increase of 9.1% from the previous total of 625,400 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment. What is Fulgent Genetics' float size? Fulgent Genetics currently has issued a total of 29,920,000 shares. Some of Fulgent Genetics' outstanding shares are available for trading, while others are subject to various restrictions. The public float, also referred to as floating shares or "the float", are shares that publicly owned, unrestricted and available to trade on the open market. Fulgent Genetics currently has a public float of 19,590,000 shares. How does Fulgent Genetics' short interest compare to its competitors? 3.48% of Fulgent Genetics' shares are currently sold short. Here is how the short interest of companies compare to Fulgent Genetics: Castle Biosciences, Inc. (5.22%), CareDx, Inc (10.57%), Celcuity Inc. (6.08%), Viridian Therapeutics, Inc. (14.59%), Sera Prognostics, Inc. (1.11%), Biodesix, Inc. (0.30%), Genetron Holdings Limited (0.08%), Burning Rock Biotech Limited (0.47%), Personalis, Inc. (3.03%), Renalytix Plc (0.81%), Which stocks are the most shorted right now? As of the most recent reporting period, the following stocks had the largest short interest positions: T-Mobile US, Inc. ($3.98 billion), Occidental Petroleum Co. ($3.35 billion), Charter Communications, Inc. ($3.06 billion), General Motors ($2.88 billion), Moderna, Inc. ($2.32 billion), Tractor Supply ($2.27 billion), Royal Caribbean Cruises Ltd. ($2.22 billion), Coinbase Global, Inc. ($2.18 billion), Williams-Sonoma, Inc. ($1.95 billion), and Chesapeake Energy Co. ($1.52 billion). View all of the most shorted stocks. What does it mean to sell short Fulgent Genetics stock? Short selling FLGT is an investing strategy that aims to generate trading profit from Fulgent Genetics as its price is falling. FLGT shares are trading down $0.39 today. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit. How does a short squeeze work against Fulgent Genetics? A short squeeze for Fulgent Genetics occurs when it has a large amount of short interest and its stock appreciates in price. This forces short sellers to cover their short interest positions by buying actual shares of FLGT, which in turn drives the price of the stock up even further. How often is Fulgent Genetics' short interest reported? Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including FLGT, twice per month. The most recent reporting period available is April, 30 2024. More Short Interest Resources from MarketBeat Related Companies: Castle Biosciences Short Squeeze CareDx Short Squeeze Celcuity Short Squeeze Viridian Therapeutics Short Squeeze Sera Prognostics Short Squeeze Biodesix Short Squeeze Genetron Short Squeeze Burning Rock Biotech Short Squeeze Personalis Short Squeeze Renalytix Short Squeeze Short Interest Tools: Stocks to Short Largest Short Interest Positions Short Interest Increases Short Interest Decreases Short Interest Reporting Dates This page (NASDAQ:FLGT) was last updated on 5/18/2024 by MarketBeat.com Staff From Our PartnersDems have chosen Biden replacement?Paradigm PressCEO of Biggest AI Chipmaker Just Dropped a Bombshell…Banyan Hill PublishingThe Overlooked Retirement Asset You Probably Don’t OwnCrypto 101 MediaCrypto Pioneer Says: “The last crypto bull market has begun.”InvestorPlaceI’m afraid WWIII is a very real possibility Porter & CompanyPOTUS in ‘25 Not Biden/Trump, ButThe Freeport SocietyMissed NVDA? Buy this AI stock NOWChaikin AnalyticsUrgent Nvidia WarningAltimetry